Pharm lecture 7 - antibodie Flashcards

0
Q

What is the FAB region?

A

antigen binding region of antibodies. variable regions of heavy and light chains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

What is the structure of antibodies?

A

2 heavy chains and 2 light chains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the FC region?

A

Constant region of heavy chain - immune effector region

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the types of IgG?

A

IgG1, IgG2, IgG3, IgG4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What type of antibody are therapeutic antibodies?

A

IgG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the characteristics of monoclonal antibodies? (4)

A

1) Homogenous for antibody type, amino acid sequence, affinity and specificity
2) High specificity
3) High Affinity
4) long half life in vivo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the following characteristics for an antibody administered subcutaneously or intramuscularly?

Bioavailability?
time till peak concentration?

A

Bioavailability: 24-95%

time till peak concentration: 7-8 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are 4 types of monoclonal antibodies and their suffix?

A

Murine: -o
Chimeric: -xi
Humanized: -zu
Human: -u

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How are antibodies administrated subcutaneously or intramuscularly absorbed? What is this route of administration limited by?

A

Absorbed slowly by convective absorption through lymph vessels and by diffusion into blood vessels

Limited by volume that can be injected at these sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Where are antibodies distributed? (3)

A

Extra-cellular distribution

Access restricted across diffusional barriers unless transport is facilitated

Does not cross blood brain barrier so does not enter CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the function of the Neonatal Fc receptor? (FcRn) (2)

A

1) Transfers passive immunity across placenta from mother to fetus (IgG antibody)
2) Protects IgG from degradation, prolonging half life in serum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What cells express the Neonatal Fc receptor? (5)

A
Hepatocytes
endothelial cells
phagocytic cells
APC
intestinal epithelium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does FcRn protect IgG from degradation? (3 steps)

A

1) IgG undergoes endocytosis into low pH endosomes promoting IgG binding to FcRn (because FcRn only binds IgG at acidic p.H.)
2) FcRn-IgG complex resistant to lysosomal enzymatic degradation - free IgG is degraded
3) GcRn-bound IgG is returned to cell surface where it dissociates at physiological p.H.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the half lives for the isotypes of IgG?

A

IgG1, IgG2, IgG4 = 20-21 days half life

IgG3 = 7 days half life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why does IgG3 have the lowest half life?

A

Because it has a single amino acid difference so that it does not bind FcRn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How long is the Murine mAB half life in humans and why?

A

12-48 hours because it does not bind with FcRn

16
Q

What is the half life of antibody fragments and why?

A

11-27 hours - lack Fc region so does not bind FcRn

17
Q

What are the mechanisms resulting from antigen-antibody binding?

A

1) Antagonism/neutralization
2) Cell signaling inhibition
3) Antibody dependent cellular cytotoxicity (ADCC)
4) Complement-dependent cytotoxicity (CDC)
5) Selective delivery of toxins or radionuclides
6) Selective imaging

18
Q

What is antagonism or neutralization?

A

Antibody acts as a competitive inhibitor blocking interaction of a soluble antigen with its ligand, thus decreasing the concentration of unbound soluble antigen in plasma

19
Q

What is Cell signaling inhibition?

A

Antibody binds cell surface signaling molecule such as a receptor or adhesion molecule to inhibit cell activation or a signaling function.

Can inactivate a pathway or activate a pathway and can act as an agonist or competitive inhibitor

can promote ADCC

20
Q

What is Anti-body dependent cellular cytotoxicity (ADCC)?

A

Antigen-bound antibody induces lysis of a target cell by an activated NK cell, neutrophl or macrophage

21
Q

Which antibodies show the greatest activity for ADCC?

A

IgG1 and IgG3

22
Q

How does an antibody cause ADCC?

A

1) Fab region binds cell surface protein on target cell
2) Fc region binds Fc receptor on NK cell or macrophages
3) NK cell releases cytotoxins or macrophage phagocytoses target cell

23
Q

What is complement-dependent cytotoxicity?

A

Antigen-bound antibody induces lysis of a target cell by activation of the complement system

24
Q

What is the mechanism of compliment-dependent cytotoxicity (CDC)?

A

1) Fab region binds a cell surface protein on the target cell
2) Fc region binds complement protein C1q and activates the complement system resulting in cell lysis

25
Q

What is the mechanism of the selective delivery of toxins or radionuclides by antibodies? (3 steps)

A

1) toxins or radionuclides are conjugated to an antibody
2) antibody binds to cell surface protein of target cell and selectively delivers the toxin or radionuclid
3) antibody-toxin complex is internalized and toxin or radionuclid released to kill target cell

26
Q

How are antibodies used for selective imaging?

A

1) Radiocontrast agent or radionuclides are conjugated to antibody
2) Antibody binds to cell surface protein on target cell and delivers imaging agent
3) Radiocontrast agent or radionuclid detected or imaged

27
Q

What is immunogenicity?

A

Antibodies are foreign proteins so they can promote generation of endogenous antibodies against the therapeutic antibody

29
Q

What are the factors that influence immunogenicity?

A

1) Fraction of foreign amino acid sequence in antibody (high for murine, low for human)
2) Increases with duration of therapy
3) More frequent with low doses
4) More likely with subcutaneous then intravenously